Market Cap

PainReform Ltd. Market Capitalization:

$2.7 Million

USD as of Jan. 1, 2026

business PainReform Ltd. Company Profile

PainReform Ltd. Main Stock Listing

NASDAQ: PRFX

Market Capitalization History of PainReform Ltd.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
MERCK Kommanditgesellschaft auf Aktien $62.01 B
Zoetis Inc. $55.81 B
Takeda Pharmaceutical Company Limited $45.42 B
Haleon plc $44.50 B
Teva Pharmaceutical Industries Limited $35.85 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of PainReform Ltd. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $2.7 M 1.88%
Jan. 1, 2025 $2.7 M 6849.64%
Jan. 1, 2024 $38,647 -27.34%
Jan. 1, 2023 $53,192 -54.55%
Jan. 1, 2022 $117,022 -75.66%
Jan. 1, 2021 $480,858

Market capitalization is calculated from the opening stock price at the beginning of each year.

PainReform Ltd. Categories

Israel languages Healthcare languages Drug Manufacturers—Specialty & Generic
Israel Healthcare Israel Drug Manufacturers—Specialty & Generic

Stocks & Indices

PainReform Ltd. has the following listings and related stock indices.


Stock: NASDAQ: PRFX

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.